Mary Panjari

Summary

Affiliation: Monash University
Country: Australia

Publications

  1. doi request reprint The safety of 52 weeks of oral DHEA therapy for postmenopausal women
    Mary Panjari
    NH and MRC Centre of Clinical Research Excellence in the Women s Health Program, Department of Medicine, Central and Eastern Clinical School, Monash University, Alfred Hospital, Prahran, Victoria, Australia
    Maturitas 63:240-5. 2009
  2. doi request reprint A randomized trial of oral DHEA treatment for sexual function, well-being, and menopausal symptoms in postmenopausal women with low libido
    Mary Panjari
    NH and MRC Centre of Clinical Research Excellence in the Women s Health Program, Department of Medicine, Central and Eastern Clinical School, Monash University, Alfred Hospital, Prahran, Victoria, Australia
    J Sex Med 6:2579-90. 2009
  3. doi request reprint DHEA for postmenopausal women: a review of the evidence
    Mary Panjari
    NH and MRC Centre of Clinical Research Excellence, Department of Medicine, Central Clinical School, Monash University, Alfred Hospital, Prahran, Victoria, Australia
    Maturitas 66:172-9. 2010
  4. doi request reprint The relationship between hormone therapy use at the time of diagnosis of breast cancer and tumor characteristics
    Mary Panjari
    Women s Health Program, Department of Medicine, Monash University Medical School, Alfred Hospital, Commercial Road, Prahran, Vic, Australia
    Horm Cancer 1:93-9. 2010
  5. doi request reprint Vaginal DHEA to treat menopause related atrophy: a review of the evidence
    Mary Panjari
    Women s Health Research Program, School of Public Health and Preventive Medicine, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
    Maturitas 70:22-5. 2011
  6. doi request reprint Methodology and challenges to recruitment to a randomized, double-blind, placebo-controlled trial of oral DHEA in postmenopausal women
    Mary Panjari
    NH and MRC Centre of Clinical Research Excellence in the Women s Health Program, Department of Medicine, Central and Eastern Clinical School, Monash University, Alfred Hospital, Prahran, Victoria, Australia
    J Womens Health (Larchmt) 17:1559-65. 2008
  7. doi request reprint Breast cancer survivors' beliefs about the causes of breast cancer
    Mary Panjari
    Women s Health Research Program, Monash University, Melbourne, Vic, Australia
    Psychooncology 21:724-9. 2012
  8. doi request reprint Clinical review: DHEA replacement for postmenopausal women
    Susan R Davis
    Women s Health Research Program, Department of Epidemiology and Preventive Medicine, Monash University, 99 Commercial Road, Melbourne, Victoria 3004, Australia
    J Clin Endocrinol Metab 96:1642-53. 2011
  9. doi request reprint Sexual function after breast cancer
    Mary Panjari
    Monash University Medical School, Alfred Hospital Women s Health Program, Department of Medicine, Prahran, Victoria, Australia
    J Sex Med 8:294-302. 2011
  10. doi request reprint Sexual function, incontinence, and wellbeing in women after rectal cancer--a review of the evidence
    Mary Panjari
    Women s Health Research Program, School of Public Health and Preventive Medicine, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia
    J Sex Med 9:2749-58. 2012

Detail Information

Publications10

  1. doi request reprint The safety of 52 weeks of oral DHEA therapy for postmenopausal women
    Mary Panjari
    NH and MRC Centre of Clinical Research Excellence in the Women s Health Program, Department of Medicine, Central and Eastern Clinical School, Monash University, Alfred Hospital, Prahran, Victoria, Australia
    Maturitas 63:240-5. 2009
    ..The aim of this study was to evaluate the safety of 52 weeks of DHEA 50mg daily oral dose given to postmenopausal women with low libido to improve sexual function...
  2. doi request reprint A randomized trial of oral DHEA treatment for sexual function, well-being, and menopausal symptoms in postmenopausal women with low libido
    Mary Panjari
    NH and MRC Centre of Clinical Research Excellence in the Women s Health Program, Department of Medicine, Central and Eastern Clinical School, Monash University, Alfred Hospital, Prahran, Victoria, Australia
    J Sex Med 6:2579-90. 2009
    ..Dehydroepiandrosterone (DHEA) and its sulfate DHEAS, which are the most abundant steroids in women, decline with age. We have shown association between low sexual function and low circulating DHEAS levels in women...
  3. doi request reprint DHEA for postmenopausal women: a review of the evidence
    Mary Panjari
    NH and MRC Centre of Clinical Research Excellence, Department of Medicine, Central Clinical School, Monash University, Alfred Hospital, Prahran, Victoria, Australia
    Maturitas 66:172-9. 2010
    ..It has been proposed that restoring the circulating levels of these steroids to those found in young women may have anti-aging effects and improve sexual function and wellbeing in postmenopausal women...
  4. doi request reprint The relationship between hormone therapy use at the time of diagnosis of breast cancer and tumor characteristics
    Mary Panjari
    Women s Health Program, Department of Medicine, Monash University Medical School, Alfred Hospital, Commercial Road, Prahran, Vic, Australia
    Horm Cancer 1:93-9. 2010
    ..01). There were no associations between HT use and either breast cancer stage or HR status. Women using systemic HT at the time of diagnosis were more likely to have lobular rather than ductal breast cancer compared with women not on HT...
  5. doi request reprint Vaginal DHEA to treat menopause related atrophy: a review of the evidence
    Mary Panjari
    Women s Health Research Program, School of Public Health and Preventive Medicine, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
    Maturitas 70:22-5. 2011
    ....
  6. doi request reprint Methodology and challenges to recruitment to a randomized, double-blind, placebo-controlled trial of oral DHEA in postmenopausal women
    Mary Panjari
    NH and MRC Centre of Clinical Research Excellence in the Women s Health Program, Department of Medicine, Central and Eastern Clinical School, Monash University, Alfred Hospital, Prahran, Victoria, Australia
    J Womens Health (Larchmt) 17:1559-65. 2008
    ..To report on the issues encountered in the recruitment of healthy naturally menopausal women in the community to a randomized placebo-controlled trial of dehydroepiandrosterone (DHEA) therapy for treatment of loss of sexual desire...
  7. doi request reprint Breast cancer survivors' beliefs about the causes of breast cancer
    Mary Panjari
    Women s Health Research Program, Monash University, Melbourne, Vic, Australia
    Psychooncology 21:724-9. 2012
    ..To explore the beliefs held by breast cancer (BC) survivors about the factors that contribute to the development of their BC. ‚ÄČ..
  8. doi request reprint Clinical review: DHEA replacement for postmenopausal women
    Susan R Davis
    Women s Health Research Program, Department of Epidemiology and Preventive Medicine, Monash University, 99 Commercial Road, Melbourne, Victoria 3004, Australia
    J Clin Endocrinol Metab 96:1642-53. 2011
    ..We have summarized the physiology of DHEA in women and reviewed the findings from randomized controlled trials (RCT) of the effects of DHEA therapy in postmenopausal women with normal adrenal function...
  9. doi request reprint Sexual function after breast cancer
    Mary Panjari
    Monash University Medical School, Alfred Hospital Women s Health Program, Department of Medicine, Prahran, Victoria, Australia
    J Sex Med 8:294-302. 2011
    ..Breast cancer (BC) remains the most common non-skin cancer in women and an increasing number are living as BC survivors...
  10. doi request reprint Sexual function, incontinence, and wellbeing in women after rectal cancer--a review of the evidence
    Mary Panjari
    Women s Health Research Program, School of Public Health and Preventive Medicine, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia
    J Sex Med 9:2749-58. 2012
    ....